Department of Surgery and Department of Clinical and Experimental Medicine, Linkoping University, Norrkoping, Sweden.
Department of Surgery, Vrinnevi Hospital, 60379, Norrkoping, Sweden.
Obes Surg. 2020 Feb;30(2):493-500. doi: 10.1007/s11695-019-04197-5.
Few studies have been carried out concerning the influence of bariatric surgery on female sexuality and hormones, particularly utilizing hormone-based questionnaires. The effect of bariatric surgery on sex hormone levels, sexual function and health-related quality of life (HRQL) in women was analyzed in this study. Participants were included in a single-center study at a regional hospital in Sweden, with a duration of one-year follow-up.
One hundred non-smoking women, undergoing laparoscopic Roux-en-Y gastric bypass, were included in the study. Blood assay for sex-hormone binding globulin (SHBG), testosterone, estrogen, progesterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) was analyzed. Participants completed the Female Sexual Function Index (FSFI), Women's Health Questionnaire (WHQ) and Psychological General Well-being Inventory (PGWB) parallel to lab testing.
At one-year follow-up, several significant results were found concerning hormones and questionnaires. Testosterone decreased and SHBG increased, N = 68/100. Desire, arousal, orgasm, satisfaction and total score domains for the FSFI increased after one year, N = 53/100. WHQ domains concerning depressed mood, somatic symptoms, memory, anxiety, sexual behavior and attractiveness improved after one year, N = 47/100. All domains in the PGWB (N = 52), including anxiety, depressed mood, positive well-being, self-control, general health, vitality and total score improved at follow-up. Spearman's Rho coefficient analysis found correlation between testosterone/WHQ-sexual problems (0.3), SHBG/WHQ-general health (0.3) and SHBG/FSFI-arousal (-0.3).
Bariatric surgery normalizes levels of sex-hormones in women, and results in improved sexual function, health-related quality of life and psychological well-being.
关于减重手术对女性性功能和激素的影响,尤其是利用基于激素的问卷进行的研究较少。本研究分析了减重手术对女性性激素水平、性功能和健康相关生活质量(HRQL)的影响。参与者被纳入瑞典一家区域医院的单中心研究,随访时间为一年。
本研究纳入了 100 名接受腹腔镜下 Roux-en-Y 胃旁路手术的不吸烟女性。分析了性激素结合球蛋白(SHBG)、睾酮、雌二醇、孕酮、卵泡刺激素(FSH)和黄体生成素(LH)的血液检测。参与者在实验室检测的同时完成了女性性功能指数(FSFI)、妇女健康问卷(WHQ)和心理一般健康问卷(PGWB)。
在一年的随访中,我们发现了一些与激素和问卷相关的显著结果。SHBG 增加,而睾酮减少,N=68/100。FSFI 的欲望、唤醒、性高潮、满意度和总分在一年后增加,N=53/100。WHQ 中与抑郁情绪、躯体症状、记忆、焦虑、性行为和吸引力相关的领域在一年后得到改善,N=47/100。PGWB 的所有领域(N=52),包括焦虑、抑郁情绪、积极幸福感、自我控制、一般健康、活力和总分,在随访时都得到了改善。Spearman's Rho 系数分析发现,睾酮/WHQ-性功能问题(0.3)、SHBG/WHQ-一般健康(0.3)和 SHBG/FSFI-唤醒(-0.3)之间存在相关性。
减重手术可使女性的性激素水平正常化,并改善性功能、健康相关生活质量和心理健康。